Search results (940)
« Back to NewsNew AI model predicts how cells choose their fate
12 May 2026
Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.
Heart scan and blood test improve risk prediction for inherited heart condition, major study finds
11 May 2026
A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) – a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.
New compound developed to target hypoxia by reducing tumour oxygen consumption
11 May 2026
Researchers from the Department of Oncology in collaboration with the Department of Chemistry have developed a promising new compound designed to reduce tumour hypoxia, a major cause of radiotherapy resistance.
Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes
8 May 2026
On World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes.
Better cognition tied to higher relapse risk after depression remission
7 May 2026
Oxford and Birmingham study with more than 3,700 UK participants challenges idea that cognitive decline would be associated with relapse risk
New study improves early detection of life threatening infection in children across South and South East Asia
6 May 2026
A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
New research programme to strengthen the evaluation of implants in the NHS
5 May 2026
A major new NIHR funded programme grant aims to make medical implants safer and better value for money in the NHS. The project will develop a robust framework to assess the long-term risks, benefits and costs of implants.
World’s largest study of women’s health marks 30 years of pioneering research
1 May 2026
Thirty years after its launch, the Million Women Study continues to shape evidence on HRT, cancer, ageing, and women’s health.
“Switching off” the ovaries reduces the risk of breast cancer recurrence by one-fifth in younger women
1 May 2026
Study shows suppressing ovarian function can significantly lower breast cancer recurrence risk in younger women already taking tamoxifen.
Inviting nature into a secure ward for young people
30 April 2026
A team from the University of Oxford and Oxford Health NHS Foundation Trust created a therapeutic horticulture garden in a psychiatric intensive care unit for young people, as part of a new study looking at how green spaces can benefit patients and staff.
Phase 2 Endometriosis study highlights a novel molecular imaging agent as a promising diagnostic and monitoring tool
29 April 2026
A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.
New rabies vaccine could provide protection for adults and children with a single dose
29 April 2026
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
New model of care could prevent more than 10,000 miscarriages a year in the UK, Tommy’s report suggests
29 April 2026
A new study by Tommy’s researchers, led by Professor Arri Coomarasamy, from the Nuffield Department of Women’s & Reproductive Health, suggests that offering follow-up care from the first miscarriage could help prevent around 10,000 pregnancy losses each year in the UK.
Research uncovers new mechanism controlling inflammation in immune cells
29 April 2026
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Antiretroviral therapy blocks rapid HIV - driven evolution of humans Oxford - led study finds
28 April 2026
A new study led by researchers at the University of Oxford demonstrates that the huge success of effective antiretroviral therapy (ART) against HIV could have altered the course of human evolution.
International collaboration tackling heart failure awarded €15 million to advance research into heart failure
28 April 2026
Professor Samira Lakhal-Littleton from the Department of Physiology, Anatomy and Genetics is part of a team of international collaborators awarded 15 million euros, including 2.6 million euros to Oxford, from the European Research Council.
Oxford researchers join €50m European study on heart health in cancer patients
28 April 2026
Researchers from the Department of Oncology are part of a €50 million European project looking at how innovative medical and digital technologies can improve the early detection of heart-related problems in cancer patients and survivors.
Study reveals lifetime obesity exposure in cancer patients is widely underestimated
27 April 2026
New data published today in the European Society for Medical Oncology (ESMO) Real World Data and Digital Oncology show that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.
University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component
25 April 2026
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease
24 April 2026
Oxford University researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.